Continuing Cancer Treatment in a “COVID HOTSPOT” in India: Are We Overestimating the Risks?

Abstract

Context: We describe the treatment of cancer patients carried out in a Government of India-designated, dedicated coronavirus disease (COVID) hospital (DCH) in a COVID hotspot in India. Aims: The aim was to study the change and delay in the management of cancer patients during the pandemic and its complications. Settings and Design: This was an observational cohort study conducted at a tertiary care center, which was also a DCH. Subjects and Methods: Cancer patients receiving cancer surgery, chemotherapy, and radiotherapy in our DCH, during the lockdown, were studied. Results: A total of 864 patients received treatment for cancer in our hospital during the period of March 20, 2020 – May 31, 2020. There were no COVID-related complications. The treatment of 109/864 patients (12.61%) was delayed due to the pandemic and lockdown situation and the treatment plan was changed for 84/864 (9.72%) patients. There were 21 deaths in these 864 patients (2.43%), but only two deaths were COVID related. Symptomatic patients were tested for COVID, and 3/864 patients (0.34%) were detected to be COVID positive. Conclusions: We successfully delivered cancer treatment to patients in our DCH. The percentage of adverse effects, symptomatic COVID infection, and related mortality has been very low in our study. Cancer care can be continued with due diligence even during this pandemic.

Keywords

Cancer surgery - cancer treatment - chemotherapy - COVID-19 pandemic - radiotherapy

• References

• 1 Krishnamurthy A, Gopinath KS. The need for prioritizing cancer surgeries amidst the COVID-19 pandemic. Indian J Surg Oncol 2020; 11: 169-70
• 2 Lei S, Jiang F, Su W, Chen C, Chen J, Mei W. et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 2020; 21: 100331
• 3 Advisory for Hospitals and Medical Institutions dated 20th March 2020. Ministry of Health and Family Welfare. Government of India.. https://www.mohfw.gov.in. Available from: [Last accessed on 2020 Jun 30]
• 4 Pramesh CS, Badwe RA. Cancer management in India during COVID-19. N Engl J Med 2020; 382: e61
• 5 Jog S, Kelkar D, Bhat M, Patwardhan S, Godavarthy P, Dhundi U. Preparedness of acute care facility and a hospital for COVID-19 pandemic: What we did!. Indian J Crit Care Med 2020; 24: 385-92 https://www.ijccm.org/doi/IJCCM/pdf/10.5005/jp-journals-10071-23416. et al. Available from: [Last accessed on 2020 Jul 02]
• 6 Cancer Patient Management during the COVID-19 Pandemic. https://Esmo.org/guidelines. Available from: [Last accessed o 2020 Jun 30]
• 7 ICMR.GOV.IN COVID-19 Testing Strategy. Revised Strategy of COVID-19 Testing in India (Version 3) 20/03/2020. https://ICMR.GOV.IN. Available from: [Last accessed on 2020 Jul 02].
• 8 Nahshon C, Bitterman A, Haddad R, Hazzan D, Lavie O. Hazardous postoperative outcomes of unexpected COVID-19 infected patients: A call for global consideration of sampling all asymptomatic patients before surgical treatment. World J Surg 2020; 44: 2477-81
• 9 Shrikhande SV, Pai PS, Bhandare MS, Bakshi G, Chaukar DA, Chaturvedi P. et al. Outcomes of elective major cancer surgery during COVID-19 at Tata Memorial Centre: Implications for cancer care policy. Ann Surg 2020; 272: e249-e252
• 10 Ghosh J, Ganguly S, Mondal D, Pandey P, Dabkara D, Biswas B. Perspective of oncology patients during COVID-19 pandemic: A prospective observational study from India. JCO Glob Oncol 2020; 6: 844-51
• 11 Cai M, Wang G, Zhang L, Gao J, Xia Z, Zhang P. et al. Performing abdominal surgery during the COVID-19 epidemic in Wuhan, China: A single-centred, retrospective, observational study. Br J Surg 2020; 107: e183-5
• 12 Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G. et al. Management of cancer surgery cases during the COVID-19 pandemic: Considerations. Ann Surg Oncol 2020; 27: 1717-20